Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,195 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

NCT02740985

Conditions: Advanced Solid Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations: Research Site Fayetteville, Arkansas, United States

Research Site Fresno, California, United States

Research Site Denver, Colorado, United States

Research Site New Haven, Connecticut, United States

View all 17 locations

View Trial Details

Completed

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

NCT01004731

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

NCT04507217

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +16 more
Locations: Cancer Center of Sun-Yat Sen University (CCSYSU) Guangzhou, Guangdong, China

Guangxi Medical University Affiliated Tumor Hospital Nanning, China

View Trial Details

Completed

The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib

NCT04179890

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Royal Marsden Hospital London, United Kingdom

View Trial Details

Completed

Atezolizumab Immunotherapy in Patients With Advanced NSCLC

NCT03102242

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

UCSD Moores Cancer Center La Jolla, California, United States

The University of Chicago Medical Center Chicago, Illinois, United States

EMMC Cancer Care Brewer, Maine, United States

View all 13 locations

View Trial Details

Completed

Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program

NCT02933346

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: CH du Pays d'Aix Aix-en-Provence, France

Clinique du Rambot Aix-en-Provence, France

CHU d'Amiens-Picardie Amiens, France

CHU d'Angers Angers, France

View all 72 locations

View Trial Details

Completed

Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements

NCT02727335

Conditions: Anaplastic Lymphoma Kinase Gene Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Agen - CH Agen, France

Angers - CHU Angers, France

Angoulême - CH Angoulême, France

Annecy - CH Annecy, France

View all 63 locations

View Trial Details

Completed

Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib

NCT03727477

Conditions: ALK Gene Rearrangement Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Aix-en-Provence - CH Aix-en-Provence, France

Angers - CHU Angers, France

Annemasse - CH Annemasse, France

Avignon - CH Avignon, France

View all 30 locations

View Trial Details

Completed

Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial

NCT02045446

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease

NCT04541407

Conditions: Bronchial Neoplasms, CNS Progression, Carcinoma, Bronchogenic, +9 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Carcinoma, Bronchogenic

Carcinoma, Bronchogenic trial results

Related conditions